DKS Incorporate is a trailblazing company specializing in bioplastic (PHA) production, with a focus on medical applications. Market Opportunity The bioplastic market is projected to grow significantly. Competitive Advantage Our proprietary production process enables us to lower the cost of production . Our flagship projects include: 1. *Orthopedic Biodegradable Implants*: Replacing traditional metal or plastic implants with biodegradable alternatives. 2. *Targeted Nano Drug Delivery System for Cancer Treatment*: Delivering cancer drugs directly to affected cells, minimizing side effects and increasing efficacy. 3. *Tissue Engineered Heart Valve*: Replacing traditional mechanical valves with tissue engineer natural valves. We're seeking investment to scale up production capacity. Key Highlights - *Unique selling proposition*: Sole producer of bioplastic (PHA) in Asia. - *Government funding*: Projects funded by Ministry of MSME and Ministry of Science and Technology.
Download the medial app to read full posts, comements and news.